Table 3.
Composition of nanoemulsion hydrogel formulations of acyclovir and their observed responses
| Formulation | X1 | X2 | X3 | Y1 | Y2 |
|---|---|---|---|---|---|
| F1 | 3 | 2 | 0.75 | 3.1 | 61 |
| F2 | 1 | 1 | 0.50 | 4.1 | 72 |
| F3 | 3 | 1 | 0.50 | 3.2 | 43 |
| F4 | 1 | 2 | 0.25 | 3.6 | 54 |
| F5 | 2 | 1 | 0.75 | 4.0 | 83 |
| F6 | 2 | 1 | 0.25 | 3.9 | 75 |
| F7 | 1 | 2 | 0.75 | 3.4 | 73 |
| F8 | 2 | 3 | 0.75 | 3.6 | 59 |
| F9 | 2 | 3 | 0.25 | 3.7 | 52 |
| F10 | 3 | 2 | 0.25 | 3.3 | 48 |
| F11 | 1 | 3 | 0.50 | 3.0 | 40 |
| F12 | 3 | 3 | 0.50 | 2.9 | 53 |
| F13 | 2 | 2 | 0.50 | 3.3 | 54 |
| F14 | 2 | 2 | 0.50 | 3.4 | 59 |
| F15 | 2 | 2 | 0.50 | 3.3 | 56 |
Notes: X1, molecular weight of chitosan; X2, percentage of chitosan; X3, percentage of Eugenol; Y1, spreadability (%); Y2, percent of ACV permeated (%).
Abbreviation: ACV, acyclovir.